Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
dc.contributor.author | Romero Martínez, Manuel Alejandro | |
dc.contributor.author | Ramos Alonso, Eva | |
dc.contributor.author | López Muñoz, Francisco | |
dc.contributor.author | Ríos, Cristóbal de los | |
dc.contributor.author | Egea, Javier | |
dc.contributor.author | Gil Martín, Emilio | |
dc.contributor.author | Pita Pita, Rene | |
dc.contributor.author | Torrado Durán, Juan José | |
dc.contributor.author | Serrano López, Dolores Remedios | |
dc.contributor.author | Juberias, Antonio | |
dc.date.accessioned | 2023-06-17T08:33:23Z | |
dc.date.available | 2023-06-17T08:33:23Z | |
dc.date.issued | 2021-04-10 | |
dc.description.abstract | Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-bearing macromolecules, such as DNA and proteins, but also produce free radicals that can develop direct toxic effects in target organs such as the eyes, skin, and respiratory system. The lack of effective treatments against vesicant CWAs-induced injury makes us consider, in this complex scenario, the use and development of melatonin-based therapeutic strategies. This multifunctional indoleamine could facilitate neutralization of the oxidative stress, modulate the inflammatory response, and prevent the DNA damage, as well as the long-term health consequences mediated by vesicant CWAs-induced epigenetic mechanisms. In this context, it would be essential to develop new galenic formulations for the use of orally and/or topically applied melatonin for the prophylaxis against vesicant CWAs, as well as the development of post-exposure treatments in the near future. | |
dc.description.department | Depto. de Farmacia Galénica y Tecnología Alimentaria | |
dc.description.faculty | Fac. de Farmacia | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | DGAM-Office Weapons and Material of the Spanish Ministry of Defense for the MELVES project | |
dc.description.sponsorship | UCJC (QUIMELTER) | |
dc.description.status | pub | |
dc.eprint.id | https://eprints.ucm.es/id/eprint/78109 | |
dc.identifier.doi | 10.3390/diseases9020027 | |
dc.identifier.issn | 2079-9721 | |
dc.identifier.officialurl | https://www.mdpi.com/journal/diseases | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/7432 | |
dc.issue.number | 2 | |
dc.journal.title | Diseases | |
dc.language.iso | eng | |
dc.page.initial | 27 | |
dc.publisher | MDPI | |
dc.relation.projectID | MELVES project | |
dc.rights | Atribución 3.0 España | |
dc.rights.accessRights | open access | |
dc.rights.uri | https://creativecommons.org/licenses/by/3.0/es/ | |
dc.subject.cdu | 615.4 | |
dc.subject.cdu | 615.9 | |
dc.subject.cdu | 615.357:623.459 | |
dc.subject.cdu | 623.459:615.357 | |
dc.subject.keyword | Sulfur and nitrogen mustard | |
dc.subject.keyword | Melatonin | |
dc.subject.keyword | Oxidative stress | |
dc.subject.keyword | Inflammation | |
dc.subject.keyword | DNA damage | |
dc.subject.keyword | Safety | |
dc.subject.keyword | Galenic formulation | |
dc.subject.ucm | Farmacia | |
dc.subject.ucm | Salud pública (Farmacia) | |
dc.subject.ucm | Tecnología farmaceútica | |
dc.subject.ucm | Toxicología (Farmacia) | |
dc.subject.ucm | Guerra | |
dc.subject.unesco | 3212 Salud Pública | |
dc.subject.unesco | 6113.05 Tratamiento de la Drogadicción | |
dc.subject.unesco | 5103.05 Guerra | |
dc.title | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? | |
dc.type | journal article | |
dc.volume.number | 9 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | c658be58-bda9-4100-ad65-bac31e1256af | |
relation.isAuthorOfPublication | 5f16335c-a2b9-4244-b00f-215f16e7150c | |
relation.isAuthorOfPublication | a577e97d-a6c8-4552-8c78-f35c42216b92 | |
relation.isAuthorOfPublication | 0aeb2999-92ef-482e-b0fc-81a9aa36ec66 | |
relation.isAuthorOfPublication.latestForDiscovery | c658be58-bda9-4100-ad65-bac31e1256af |
Download
Original bundle
1 - 1 of 1